Yifang Bio Stock Plunges 30%: Is the AI Drug Discovery Sector Losing Steam?
In the spring of 2026, Yifang Bio — once hailed as the 'Disneyland of Pharma' — saw its stock price plunge over 30%, tri…
🏷️ AI Pharmaceuticals
3 articles about 'AI Pharmaceuticals'
Chengda Biotech Invests 1 Billion Yuan to Establish AI Pharmaceutical Tech Company in Shanghai
Liaoning Chengda Biotech has established a wholly-owned subsidiary, Shanghai Chengda Zhiyuan Pharmaceutical Technology C…
Fosun Pharma Q1 Net Profit Reaches 871 Million Yuan, Up 13.87% Year-on-Year
Fosun Pharma released its Q1 2026 earnings report, posting revenue of 10.073 billion yuan, up 6.93% year-on-year, and ne…
1